The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 15, 2015

Filed:

Sep. 13, 2010
Applicants:

Amir Pesyan, Park City, UT (US);

Manuel F. Balandrin, Sandy, UT (US);

Inventors:

Amir Pesyan, Park City, UT (US);

Manuel F. Balandrin, Sandy, UT (US);

Assignee:

AURIMMED PHARMA, INC., Salt Lake City, UT (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/165 (2006.01); C07C 233/11 (2006.01); C07D 295/155 (2006.01); A61K 31/353 (2006.01); A61K 31/36 (2006.01); A61K 31/44 (2006.01); A61K 31/445 (2006.01); A61K 31/495 (2006.01); A61K 31/5375 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C07D 295/155 (2013.01); A61K 31/165 (2013.01); A61K 31/353 (2013.01); A61K 31/36 (2013.01); A61K 31/44 (2013.01); A61K 31/445 (2013.01); A61K 31/495 (2013.01); A61K 31/5375 (2013.01); A61K 45/06 (2013.01);
Abstract

A series of novel compounds showing anticonvulsant, chemical countermeasure(s), and analgesic activities is described. Such pharmaceutically active compounds may also show utility in the treatment of other central nervous system ('CNS') diseases and disorders, such as anxiety, depression, insomnia, migraine headaches, schizophrenia, Parkinson's disease, spasticity, Alzheimer's disease, and bipolar disorder. Furthermore, such compounds may additionally find utility as analgesics (e.g., for the treatment of chronic or neuropathic pain) and as neuroprotective agents useful in the treatment of stroke(s), chronic neurodegenerative diseases (such as Alzheimer's disease and Huntington's disease), and/or traumatic brain and/or spinal cord injuries. Moreover, these/such compounds may also be useful in the treatment of status epilepticus and/or as chemical countermeasures.


Find Patent Forward Citations

Loading…